VBI Vaccines (VBIV)
(Delayed Data from NSDQ)
$0.64 USD
-0.01 (-1.39%)
Updated May 28, 2024 04:00 PM ET
After-Market: $0.64 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.32 | 0.00% |
Earnings Summary
For their last quarter, VBI Vaccines (VBIV) reported earnings of -$0.55 per share, missing the Zacks Consensus Estimate of -$0.53 per share. This reflects a negative earnings surprise of 3.77%. Look out for VBIV's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.32 per share, reflecting a year-over-year increase of 85.25%.
Earnings History
Price & Consensus
Zacks News for VBIV
Atara Biotherapeutics (ATRA) Reports Q2 Loss, Lags Revenue Estimates
VBIV: What are Zacks experts saying now?
Zacks Private Portfolio Services